Mestinon

Myasthenic Syndromes, Congenital, Constipation, Gas Poisoning + 6 more
Treatment
20 Active Studies for Mestinon

What is Mestinon

PyridostigmineThe Generic name of this drug
Treatment SummaryMyasthenia gravis is a condition that causes the muscles to weaken and tire easily. Pyridostigmine is a medication used to treat myasthenia gravis. It works by blocking the breakdown of acetylcholine, a chemical in the body that helps muscles move. Pyridostigmine was first approved by the FDA in 1955 and is available in tablets, syrups, and injections. It is also used to reverse nerve blocks, ease symptoms of congenital myasthenic syndromes, and protect against certain nerve agents.
Mestinonis the brand name
image of different drug pills on a surface
Mestinon Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Mestinon
Pyridostigmine
1955
38

Effectiveness

How Mestinon Affects PatientsPyridostigmine bromide is taken orally and works by blocking an enzyme (cholinesterase) that breaks down certain chemicals in the body. It is similar to another drug (neostigmine) but has fewer side effects and lasts longer. If too much of the drug is taken, it can cause a cholinergic crisis, which shows symptoms similar to a myasthenic crisis. In this case, atropine is usually given to counteract the side effects.
How Mestinon works in the bodyMyasthenia gravis is an autoimmune condition that affects the way nerve signals reach muscles. It is caused by antibodies that bind to molecules involved in these signals, like the acetylcholine receptor. This reduces the ability of the nerve to communicate with the muscles, causing weakness and fatigue. Pyridostigmine is a drug used to treat myasthenia gravis. It works by blocking an enzyme called acetylcholinesterase, which breaks down the molecules involved in nerve-muscle communication. This increases the amount of the molecules available, resulting in improved nerve-muscle communication and improved

When to interrupt dosage

The suggested quantity of Mestinon is contingent upon the diagnosed circumstance, including non-depolarizing neuromuscular blocking agents, Neuromuscular Blockade and Gas Poisoning. The amount of dosage is contingent upon the method of delivery (e.g. Oral or Solution - Oral) detailed in the table below.
Condition
Dosage
Administration
Gas Poisoning
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Gas Poisoning
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Hypotension, Orthostatic
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
non-depolarizing neuromuscular blocking agents
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Myasthenic Syndromes, Congenital
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Constipation
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Neuromuscular Blockade
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Myasthenia Gravis
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral
Postpoliomyelitis Syndrome
, 180.0 mg, 60.0 mg, 5.0 mg/mL, 60.0 mg/mL, 30.0 mg
, Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Tablet - Oral, Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous; Parenteral, Liquid, Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Syrup - Oral, Solution, Solution - Oral

Warnings

Mestinon has three contraindications and must not be combined with the conditions listed in the ensuing table.Mestinon Contraindications
Condition
Risk Level
Notes
Mechanical Intestinal Obstruction
Do Not Combine
mechanical urinary obstructions
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Pyridostigmine may interact with Pulse Frequency
There are 20 known major drug interactions with Mestinon.
Common Mestinon Drug Interactions
Drug Name
Risk Level
Description
Acetylcholine
Minor
The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Acetylcholine.
Agmatine
Minor
The therapeutic efficacy of Agmatine can be decreased when used in combination with Pyridostigmine.
Alcuronium
Minor
The therapeutic efficacy of Alcuronium can be decreased when used in combination with Pyridostigmine.
Amantadine
Minor
The therapeutic efficacy of Amantadine can be decreased when used in combination with Pyridostigmine.
Amitriptyline
Minor
The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Pyridostigmine.
Mestinon Toxicity & Overdose RiskNot much is known about the toxic effects of pyridostigmine. Overdosing may lead to a range of adverse effects, including slow heartbeat, excessive mucus in the lungs, and a cholinergic crisis. To treat an overdose, doctors may suggest supportive treatments.
image of a doctor in a lab doing drug, clinical research

Mestinon Novel Uses: Which Conditions Have a Clinical Trial Featuring Mestinon?

59 active clinical trials are currently assessing the potential of Mestinon to alleviate Myasthenic Syndromes, Congenital Disorders, Chronic Constipation and Gas Poisoning.
Condition
Clinical Trials
Trial Phases
Myasthenia Gravis
17 Actively Recruiting
Phase 2, Phase 3, Phase 1, Not Applicable
Constipation
16 Actively Recruiting
Phase 2, Not Applicable, Phase 4, Phase 3
Hypotension, Orthostatic
21 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Early Phase 1, Phase 3, Phase 4
Neuromuscular Blockade
1 Actively Recruiting
Not Applicable
Myasthenic Syndromes, Congenital
1 Actively Recruiting
Phase 1
Gas Poisoning
0 Actively Recruiting
non-depolarizing neuromuscular blocking agents
0 Actively Recruiting
Gas Poisoning
0 Actively Recruiting
Postpoliomyelitis Syndrome
0 Actively Recruiting

Mestinon Reviews: What are patients saying about Mestinon?

5Patient Review
7/24/2015
Mestinon for Myasthenia Gravis
The only problem I have is that mestinon has given me an irregular heart rhythm, which I read is a side effect.
5Patient Review
1/9/2017
Mestinon for Myasthenia Gravis
I was diagnosed with myasthenia gravis in 2002. I started taking this medication in liquid form, but as I've gotten older I only need to take it three times a day. It's been effective overall, though I have experienced some leg cramps and muscle spasms as side effects. Another downside is that it doesn't seem to help much with drooping eyelids.
5Patient Review
9/28/2015
Mestinon for Myasthenia Gravis
I've been taking this medication for almost 30 years now. When I first started, the muscle spasms were really bad. But after a few months, my body got used to it and the fatigue eased up. I take 60mg in the morning with food, 2-3 PM and before I go to bed.
5Patient Review
3/24/2017
Mestinon for Myasthenia Gravis
I've been taking this for almost a decade now, and it's still helping me. Within hours of taking the first dose, I saw marked improvement. Recently had to switch to liquid form due to insurance issues, which I'm not thrilled about; however, it's still better than nothing.
4.7Patient Review
6/1/2018
Mestinon for Myasthenia Gravis
I had been dealing with undiagnosed myasthenia gravis for five months before finally being admitted to the hospital. The team of neurologists there quickly diagnosed and treated me; and within hours, all of my symptoms and problems were gone. This drug quite literally worked miracles for me.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about mestinon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of the medication Mestinon?

"You may experience nausea, vomiting, diarrhea, abdominal cramps, increased saliva/sweating, runny nose, decreased pupil size, or increased urination. If you experience any of these effects for an extended period of time, or if they worsen, tell your doctor or pharmacist."

Answered by AI

What are the benefits of Mestinon?

"Acetylcholine is needed for the proper functioning of your nerve cells and muscles.

MESTINON is a treatment for myasthenia gravis, which is a condition that results in muscle weakness and fatigue, especially with repeated use. MESTINON is a cholinergic antimyasthenic, which is a group of medicines that work by preventing the breakdown of a chemical called acetylcholine. Acetylcholine is necessary for the proper functioning of your nerve cells and muscles."

Answered by AI

Who should not take Mestinon?

"You shouldn't take Mestinon if you're allergic to it or if you have a bladder or bowel obstruction. Make sure it's safe for you to take Mestinon by telling your doctor if you have asthma or kidney disease."

Answered by AI

What is the drug Mestinon used for?

"MESTINON is a medication used to treat myasthenia gravis, a long term condition that causes weakened and easily tired muscles, especially after repeated use. It is also used to treat postoperative urinary retention, a condition where an individual is unable to urinate after surgery."

Answered by AI

Clinical Trials for Mestinon

Have you considered Mestinon clinical trials? We made a collection of clinical trials featuring Mestinon, we think they might fit your search criteria.
Have you considered Mestinon clinical trials? We made a collection of clinical trials featuring Mestinon, we think they might fit your search criteria.
Have you considered Mestinon clinical trials? We made a collection of clinical trials featuring Mestinon, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top